CGMP/Finished Pharmaceuticals/Adulterated/Unapproved New Drug/Misbranded
Similar Posts
Current Good Manufacturing Practice for Medical Gases
Pharmaceutical Quality/Manufacturing Standards (CGMP)Summary Metrics of Drug Development Tool Qualification Projects Submitted to FDA
This Table provides the current number of active CDER Drug Development Tool (DDT) Qualification projects overall and by Program (DDT- Animal Model Qualification Program, DDT- Biomarker Qualification Program, DDT- Clinical Outcomes Assessment [COA] Qualification Program). Numbers are also provided byArtificial Intelligence for Drug Development
FDA recognizes the increased use of AI throughout the drug development process and across a range of therapeutic areas. Learn more.American Behavioral Research Institute, LLC – 705629 – 04/30/2025
Clinical Investigator (Sponsor)Advisory Letters
Advisory LettersCommissioner’s National Priority Voucher (CNPV) Pilot Program
FDA Commissioner’s National Priority Voucher Program. The Commissioner’s National Priority Voucher Program offers an unprecedented opportunity to reduce drug and biologic review times from 10-12 months to just 1-2 months.